Table 3. Summary of methodologies used in the investigations.
AI: artificial intelligence, ML: machine learning
Methodology | Description | Percentage of studies |
Imaging Data Analysis with AI/ML Models | Utilized advanced AI/ML models like convolutional neural networks and radiomics analysis to analyze imaging data from modalities such as MRI, PET, and CT for diagnosis, prognosis, and prediction. | 24% |
Animal Models and In Vitro Assays | Employed animal models and in vitro assays, including techniques like immunohistochemistry and electrophysiological recordings, to evaluate nerve injury, therapeutic approaches, and drug efficacy. | 24% |
Analysis of Electronic Health Records and Patient Data | Applied AI/ML techniques to examine electronic health records, demographic information, and clinical laboratory tests to construct diagnostic, prognostic, and predictive models. | 12% |
Research on Robotic Devices for Rehabilitation | Utilized robotic systems and devices to deliver specific stimulation patterns for rehabilitating nerve damage and restoring normal function. | 12% |
Computational Modeling and Simulations | Employed computational techniques like ML and mathematical modeling to explore pharmacological targets and neural signaling. | 6% |
Analysis of Human Subject Data | Conducted data collection and analysis on human subjects, including symptoms, neuropsychological assessments, and imaging data, to develop AI/ML models. | 6% |